94 related articles for article (PubMed ID: 2622081)
1. [Radioimmunoimaging of malignant melanoma with In-111-labeled monoclonal antibodies 96.5 and ZME 018].
Oyamada H; Ishihara K; Fukukita H; Hayasaka K
Kaku Igaku; 1989 Dec; 26(12):1503-12. PubMed ID: 2622081
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunoimaging of malignant melanoma with In-111 labeled monoclonal antibody 96.5 and ZME-0.18].
Ishii K; Nishiyama S; Oyamada H; Endo K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1194-203. PubMed ID: 2730019
[TBL] [Abstract][Full Text] [Related]
3. Uptake of indium-111-labeled monoclonal antibody ZME-018 as a function of tumor size in a patient with melanoma.
Macey DJ; Denardo SJ; Denardo GL; Goodnight JK; Unger MW
Am J Physiol Imaging; 1988; 3(1):1-6. PubMed ID: 3390350
[TBL] [Abstract][Full Text] [Related]
4. Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma.
Frontiera M; Murray JL; Lamki L; Thomas J; Satterlee W; Schmelter R; Rosenblum MG; Khazaeli MB; Unger MW; Robinson WA
Clin Nucl Med; 1989 May; 14(5):357-66. PubMed ID: 2656042
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of metastatic melanoma with planar and SPECT scintigraphy using ZME 018 and 96.5 radiolabeled monoclonal antibodies.
Jaffe RM; Alderson PO; Seldin DW; Esser PD; Bartholomew RM; Hyman GA
Cancer Detect Prev; 1988; 12(1-6):303-12. PubMed ID: 3263197
[TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy and pharmacokinetics of indium-111-labeled ZME-018 monoclonal antibody in patients with malignant melanoma.
Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Arano Y; Miyachi Y; Kashihara-Sawami M; Imamura S
Jpn J Cancer Res; 1988 Aug; 79(8):973-81. PubMed ID: 3141332
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.
Murray JL; Rosenblum MG; Lamki L; Haynie TP; Glenn HJ; Plager CE; Unger MW; Carlo DJ; Hersh EM
NCI Monogr; 1987; (3):3-9. PubMed ID: 3821916
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018).
Kirkwood JM; Neumann RD; Zoghbi SS; Ernstoff MS; Cornelius EA; Shaw C; Ziyadeh T; Fine JA; Unger MW
J Clin Oncol; 1987 Aug; 5(8):1247-55. PubMed ID: 3625247
[TBL] [Abstract][Full Text] [Related]
9. [Imaging of malignant melanoma with In-111-labeled monoclonal antibody (ZME-018) and Ga-67 scintigraphy].
Murakami K; Minoshima S; Uno K; Arimizu N; Kobayashi M; Fujita M; Okamoto S; Ikehira H; Fukuda H; Tateno Y
Kaku Igaku; 1989 Jan; 26(1):113-9. PubMed ID: 2724630
[No Abstract] [Full Text] [Related]
10. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibody.
Taylor A; Milton W; Eyre HP; Christian P; Wu F; Hagan P; Alazraki N; Datz FL; Unger M
J Nucl Med; 1988 Mar; 29(3):329-37. PubMed ID: 3346743
[TBL] [Abstract][Full Text] [Related]
11. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
[TBL] [Abstract][Full Text] [Related]
12. Effect of unlabelled monoclonal antibody (MoAb) on biodistribution of 111indium labelled (MoAb).
Lamki LM; Murray JL; Rosenblum MG; Patt YZ; Babaian R; Unger MW
Nucl Med Commun; 1988 Aug; 9(8):553-64. PubMed ID: 3173914
[TBL] [Abstract][Full Text] [Related]
13. Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants.
Krizan Z; Murray JL; Hersh EM; Rosenblum MG; Glenn HJ; Gschwind CR; Carlo DJ
Cancer Res; 1985 Oct; 45(10):4904-9. PubMed ID: 2411391
[TBL] [Abstract][Full Text] [Related]
14. Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection.
Halpern SE; Haindl W; Beauregard J; Hagan P; Clutter M; Amox D; Merchant B; Unger M; Mongovi C; Bartholomew R
Radiology; 1988 Aug; 168(2):529-36. PubMed ID: 3393677
[TBL] [Abstract][Full Text] [Related]
15. Intrapatient and interpatient comparison of tumor size and monoclonal antibody uptake in melanoma.
Cornelius EA; Neumann RD; Zoghbi SS; Kirkwood JM; Ernstoff MS; Unger MM
Clin Nucl Med; 1988 Apr; 13(4):243-9. PubMed ID: 3370893
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.
Murray JL; Rosenblum MG; Sobol RE; Bartholomew RM; Plager CE; Haynie TP; Jahns MF; Glenn HJ; Lamki L; Benjamin RS
Cancer Res; 1985 May; 45(5):2376-81. PubMed ID: 3986779
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoimaging in malignant melanoma with monoclonal antibodies.
Repetto L; Scopinaro G; Michelotti A; Claudiani F; Fusco V; Grimaldi A; Sertoli MR; Rosso R
Oncology; 1988; 45(5):392-5. PubMed ID: 3412750
[TBL] [Abstract][Full Text] [Related]
18. Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodies.
Rosenblum MG; Murray JL; Lamki L; David G; Carlo D
Cancer Chemother Pharmacol; 1987; 20(1):41-7. PubMed ID: 3621452
[TBL] [Abstract][Full Text] [Related]
19. Comparison of gallium-67 versus indium-111 monoclonal antibody (96.5, ZME-018) in detection of human melanoma in athymic mice.
Chan SM; Hoffer PB; Maric N; Zoghbi SS; Kirkwood JM; Ernstoff MS; Duray PH; Gerich B
J Nucl Med; 1987 Sep; 28(9):1441-6. PubMed ID: 3476691
[TBL] [Abstract][Full Text] [Related]
20. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.
Siccardi AG; Buraggi GL; Callegaro L; Mariani G; Natali PG; Abbati A; Bestagno M; Caputo V; Mansi L; Masi R
Cancer Res; 1986 Sep; 46(9):4817-22. PubMed ID: 3731128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
